Neoadjuvant B-RAF and MEK inhibitor targeted therapy for adult papillary craniopharyngiomas: a new treatment paradigm
F. Calvanese,
T. Jacquesson,
R. Manet,
A. Vasiljevic,
H. Lasolle,
F. Ducray,
G. Raverot,
E. Jouanneau
Affiliations
F. Calvanese
Hôpital Pierre Wertheimer, Pituitary and Skull Base Neurosurgical Department, Bron, France
T. Jacquesson
Hôpital Pierre Wertheimer, Pituitary and Skull Base Neurosurgical Department, Bron, France; Lyon University, Université Claude Bernard Lyon 1, Lyon, France
R. Manet
Hôpital Pierre Wertheimer, Pituitary and Skull Base Neurosurgical Department, Bron, France
A. Vasiljevic
Hôpital Pierre Wertheimer, Pathology, Bron, France
H. Lasolle
Hôpital Pierre Wertheimer, Endocrinology , Reference Center for Rare Pituitary Diseases HYPO, Bron, France
F. Ducray
Hôpital Pierre Wertheimer, Neuro-Oncology, Bron, France; Cancer Research Center of Lyon, INSERM U 1052, CNRS UMR 5286, Lyon, France; Lyon University, Université Claude Bernard Lyon 1, Lyon, France
G. Raverot
Hôpital Pierre Wertheimer, Endocrinology , Reference Center for Rare Pituitary Diseases HYPO, Bron, France; Cancer Research Center of Lyon, INSERM U 1052, CNRS UMR 5286, Lyon, France; Lyon University, Université Claude Bernard Lyon 1, Lyon, France
E. Jouanneau
Hôpital Pierre Wertheimer, Chairmain of Pituitary and Skull Base Neurosurgical Department, Bron, France; Lyon University, Université Claude Bernard Lyon, Lyon, France; Cancer Research Center of Lyon, INSERM U 1052, CNRS UMR 5286, Lyon, France
